Halozyme Therapeutics, Inc. (HALO)

110.19 -0.57 (-0.51%) USD  |  NASDAQ  |  Sep 04, 16:00
109.96 -0.23 (-0.21%) After-Hours: 20:00
More

Halozyme Therapeutics EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical EPS LT Growth Estimates Data

View and export this data back to 2021. Start Trial.
Date Value
August 07, 2024 --
June 20, 2024 --
November 28, 2022 --
February 23, 2022 --
Date Value
January 13, 2022 --
January 07, 2022 --
November 23, 2021 --
November 03, 2021 --

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Incyte Corp. Upgrade
AVITA Medical, Inc. Upgrade
BioCryst Pharmaceuticals, Inc. --
Neurocrine Biosciences, Inc. Upgrade
Iovance Biotherapeutics, Inc. --